Circulation, Vol 74, 145-156, Copyright © 1986 by American Heart Association
T Aherne, D Tscholakoff, W Finkbeiner, U Sechtem, N Derugin, E Yee and CB Higgins
The purpose of this study was to evaluate the potential of magnetic
resonance imaging (MRI) in vivo for the characterization of tissue changes
associated with acute myocardial rejection after cardiac transplantation.
Of 15 dogs that underwent heterotopic cardiac transplantation, six served
as untreated controls, and nine received immunosuppressive therapy (25
mg/kg/day cyclosporine, 1 mg/kg/day prednisone). Serial
electrocardiographically gated MRI (spin-echo technique) and histologic
examinations of allograft biopsy samples were performed for each dog at 2
to 3, 7 to 10, 14 to 17, and 26 to 29 days after transplantation and
immediately after animals were killed. Untreated allografts showed a
significant increase (p less than .01) in T2 (spin-spin) relaxation time
(T2 = 66 +/- 8 msec) and intensity values compared with values in the
native hearts (T2 = 44 +/- 6 msec) as early as 1 week after
transplantation. The significant difference in T2 values could be observed
in vivo as well as on postmortem examination and corresponded to histologic
progression of the rejection process. There was no significant difference
in T1, T2, or intensity values in cyclosporine-treated allografts and
native hearts except in two dogs in which T2 relaxation times and signal
intensity in the transplanted hearts increased simultaneously with
histologic evidence of rejection, indicating failure of immunosuppressive
therapy. There was a significant correlation between histologic grading of
severity of rejection and T2 relaxation times of the cardiac transplants (r
= .72). Likewise, there was a significant linear relationship between T2
values in vivo and percent water content when the differences between
native hearts and allografts were compared (r = .92, p less than
.001).(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Magnetic resonance imaging of cardiac transplants: the evaluation of rejection of cardiac allografts with and without immunosuppression
This article has been cited by other articles:
![]() |
A. Zagrosek, H. Abdel-Aty, P. Boye, R. Wassmuth, D. Messroghli, W. Utz, A. Rudolph, S. Bohl, R. Dietz, and J. Schulz-Menger Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. J. Am. Coll. Cardiol. Img., February 1, 2009; 2(2): 131 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Y. Marie, M. Angioi, J. P. Carteaux, J. M. Escanye, S. Mattei, K. Tzvetanov, O. Claudon, N. Hassan, N. Danchin, G. Karcher, et al. Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence J. Am. Coll. Cardiol., March 1, 2001; 37(3): 825 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Walpoth, M. F. Muller, B. Celik, B. Nicolaus, N. Walpoth, T. Schaffner, U. Althaus, and T. Carrel Assessment of cardiac rejection by MR-imaging and MR-spectroscopy Eur. J. Cardiothorac. Surg., October 1, 1999; 14(4): 426 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P Bidstrup Review article : Blood conservation in cardiac surgery: can drugs help? Perfusion, July 1, 1988; 3(3): 171 - 177. [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |